439 related articles for article (PubMed ID: 17495595)
1. Plasminogen activator inhibitor-1, adipose tissue and insulin resistance.
Alessi MC; Poggi M; Juhan-Vague I
Curr Opin Lipidol; 2007 Jun; 18(3):240-5. PubMed ID: 17495595
[TBL] [Abstract][Full Text] [Related]
2. Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity.
Juhan-Vague I; Alessi MC; Morange PE
Ann Med; 2000 Dec; 32 Suppl 1():78-84. PubMed ID: 11209987
[TBL] [Abstract][Full Text] [Related]
3. Functional role of the fibrinolytic system in development of adipose tissue.
Lijnen HR
Verh K Acad Geneeskd Belg; 2009; 71(3):101-13. PubMed ID: 20088250
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines.
He G; Andersen O; Haugaard SB; Lihn AS; Pedersen SB; Madsbad S; Richelsen B
Eur J Clin Invest; 2005 Sep; 35(9):583-90. PubMed ID: 16128865
[TBL] [Abstract][Full Text] [Related]
5. [PAI-1, the primary plasmatic inhibitor of fibrinolysis. Physiopathologic role and molecular mechanisms].
Banfi C; Mussoni L; Tremoli E
Minerva Endocrinol; 2002 Sep; 27(3):181-91. PubMed ID: 12091793
[TBL] [Abstract][Full Text] [Related]
6. [The auto- and endocrine function of the adipose tissue. Significance for metabolic complications in obesity].
Richelsen B; Kristensen K; Jensen JD
Ugeskr Laeger; 1998 Dec; 160(50):7246-50. PubMed ID: 9859722
[TBL] [Abstract][Full Text] [Related]
7. Monocyte chemotactic protein-1 and its role in insulin resistance.
Sell H; Eckel J
Curr Opin Lipidol; 2007 Jun; 18(3):258-62. PubMed ID: 17495598
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory cytokines interleukin-6 and oncostatin m induce plasminogen activator inhibitor-1 in human adipose tissue.
Rega G; Kaun C; Weiss TW; Demyanets S; Zorn G; Kastl SP; Steiner S; Seidinger D; Kopp CW; Frey M; Roehle R; Maurer G; Huber K; Wojta J
Circulation; 2005 Apr; 111(15):1938-45. PubMed ID: 15837947
[TBL] [Abstract][Full Text] [Related]
9. Regional variation in plasminogen activator inhibitor-1 expression in adipose tissue from obese individuals.
Eriksson P; Van Harmelen V; Hoffstedt J; Lundquist P; Vidal H; Stemme V; Hamsten A; Arner P; Reynisdottir S
Thromb Haemost; 2000 Apr; 83(4):545-8. PubMed ID: 10780314
[TBL] [Abstract][Full Text] [Related]
10. Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation.
Alessi MC; Bastelica D; Mavri A; Morange P; Berthet B; Grino M; Juhan-Vague I
Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1262-8. PubMed ID: 12750120
[TBL] [Abstract][Full Text] [Related]
11. Hypofibrinolysis in the insulin resistance syndrome: implication in cardiovascular diseases.
Mavri A; Alessi MC; Juhan-Vague I
J Intern Med; 2004 Apr; 255(4):448-56. PubMed ID: 15049879
[TBL] [Abstract][Full Text] [Related]
12. Food deprivation induces adipose plasminogen activator inhibitor-1 (PAI-1) expression without accumulation of plasma PAI-1 in genetically obese and diabetic db/db mice.
Oishi K; Ohkura N; Matsuda J; Ishida N
Thromb Haemost; 2007 Oct; 98(4):864-70. PubMed ID: 17938813
[TBL] [Abstract][Full Text] [Related]
13. PAI-1 and the metabolic syndrome: links, causes, and consequences.
Alessi MC; Juhan-Vague I
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2200-7. PubMed ID: 16931789
[TBL] [Abstract][Full Text] [Related]
14. Fat cell function and fibrinolysis.
Alessi MC; Morange P; Juhan-Vague I
Horm Metab Res; 2000; 32(11-12):504-8. PubMed ID: 11246816
[TBL] [Abstract][Full Text] [Related]
15. Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly.
Yamamoto K; Takeshita K; Kojima T; Takamatsu J; Saito H
Cardiovasc Res; 2005 May; 66(2):276-85. PubMed ID: 15820196
[TBL] [Abstract][Full Text] [Related]
16. Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1.
Skurk T; Hauner H
Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1357-64. PubMed ID: 15356668
[TBL] [Abstract][Full Text] [Related]
17. Modulation of adipose tissue development by pharmacological inhibition of PAI-1.
Crandall DL; Quinet EM; El Ayachi S; Hreha AL; Leik CE; Savio DA; Juhan-Vague I; Alessi MC
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2209-15. PubMed ID: 16825598
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor-1 and the circadian clock in metabolic disorders.
Oishi K
Clin Exp Hypertens; 2009 May; 31(3):208-19. PubMed ID: 19387897
[TBL] [Abstract][Full Text] [Related]
19. Adipocyte-derived factors potentiate nutrient-induced production of plasminogen activator inhibitor-1 by macrophages.
Kishore P; Li W; Tonelli J; Lee DE; Koppaka S; Zhang K; Lin Y; Kehlenbrink S; Scherer PE; Hawkins M
Sci Transl Med; 2010 Feb; 2(20):20ra15. PubMed ID: 20371491
[TBL] [Abstract][Full Text] [Related]
20. [Insulin resistance and adipose tissue gene expression in humans].
Bastard JP
Ann Biol Clin (Paris); 2004; 62(1):25-31. PubMed ID: 15047487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
